FDA coordinates with pharma to address IV fluid shortage

The FDA's Center for Veterinary Medicine announced on April 13 that it has a plan in place to address a shortage of IV fluids used to treat large animals. The shortage of 3-litre and 5-litre doses has been caused by a combination of increased demand and decreased production, according to a statement from the FDA. Manufacturers have responded by shifting production to smaller sizes, which can be used for treating people and pets but not larger animals. The agency plans to work with several pharma companies that are preparing to import IV fluids from foreign countries to help ease the shortage, the agency says. Release